LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) today announced the
appointment of Ronald A. Matricaria as a Director and Chairman of the
Board. Mr. Matricaria replaces Kathleen ("Kathy") Regan, who has served
as Interim Chair since January. Ms. Regan will continue to serve as an
independent director for the Company and Chair of the Nominating and
Governance Committee.
"On behalf of the Board of Directors, I am delighted to welcome Ron as
Chairman," said Kathy Regan. "His wealth of experience as both an
executive and director in the medical device industry will be
instrumental in successfully building the company to the next level. I
see this significant event as an example of the efforts being made to
position the Company for long-term stability and growth."
Mr. Matricaria has more than 35 years of medical device and
pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and
Company. He is also currently Chairman of the Board at Volcano
Corporation Inc., a member of the Board at Phoenix Children's Hospital
and, most recently, served as a Director at Life Technologies
Corporation.
Mr. Matricaria commented on his new appointment, "I am very excited to
have the opportunity to work with the Orthofix team to realize the true
potential of this Company. The business has been through a lot over the
last few years, but I strongly believe that with the appropriate
direction and guidance, we have the opportunity to create substantial
shareholder value."
President and Chief Executive Officer Brad Mason said, "Having Ron join
our team as Chairman of the Board represents a major step in achieving
our vision for Orthofix. With the active and experienced board we are
putting in place, I am confident we can build the foundation to maximize
the value of our technologies, core competencies, and relationships. I
want to thank Kathy on behalf of all the employees at Orthofix for her
tireless work in getting us to this point as Interim Chair."
Ronald A. Matricaria
With more than 35 years of medical device and pharmaceutical experience,
Mr. Matricaria served as President and Chief Executive Officer of St.
Jude Medical, Inc. and served as Chairman of the Board of Directors.
Prior to joining St. Jude Medical, Inc., he was with Eli Lilly and
Company where he held multiple executive positions over the course of 23
years. Mr. Matricaria is also currently Chairman of the Board at Volcano
Corporation, a member of the Board at Phoenix Children's Hospital and,
most recently, served on the Board of Directors of Life Technologies
Corporation. Additionally, Mr. Matricaria has served on the board of a
number of public and private companies including Home Depot Inc.,
Diametric Medical Inc., Ceridian Inc., Centocor Inc., Haemonetics Inc.,
Kinetic Concepts, Inc., Hospira Inc., Cyberonics Inc., Vistacare Inc.,
Advanced Medical Technology Association (AdvaMed), the Pharmaceutical
Manufacturers Association International Section, the American Diabetes
Association, the American Foundation for Pharmaceutical Education, the
National Foundation for Infectious Diseases, the National Retiree
Volunteer Center and the Indiana Repertory Theatre as well as a trustee
on the board of the Massachusetts College of Pharmacy and Allied Health
Science. He also chaired the BioMedical Engineering Institute campaign,
which raised an operating endowment for the Institute at the University
of Minnesota. He remains a Trustee emeritus of the University of
Minnesota Foundation.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, TX, the company has
four strategic business units that include BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the company's sales representatives, stocking distributors and its
subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation, the Orthopedic Research and
Education Foundation and the Texas Scottish Rite Hospital for Children.
For more information, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Source: Orthofix International N.V.
News Provided by Acquire Media